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Altered Nitric Oxide Bioavailability Contributes to Diesel Exhaust
Inhalation-Induced Cardiovascular Dysfunction in Man
Jeremy P. Langrish, MRCP, PhD; Jon Unosson, MD; Jenny Bosson, MD, PhD; Stefan Barath, MD, PhD; Ala Muala, MD; Scott Blackwell, PhD;
Stefan S€oderberg, MD, PhD; Jamshid Pourazar, PhD; Ian L. Megson, PhD; Andrew Treweeke, PhD; Thomas Sandstr€om, MD, PhD;
David E. Newby, DM, PhD; Anders Blomberg, MD, PhD; Nicholas L. Mills, MRCP, PhD
Background-—Diesel exhaust inhalation causes cardiovascular dysfunction including impaired vascular reactivity, increased blood
pressure, and arterial stiffness. We investigated the role of nitric oxide (NO) bioavailability in mediating these effects.
Methods and Results-—In 2 randomized double-blind crossover studies, healthy nonsmokers were exposed to diesel exhaust or
ﬁltered air. Study 1: Bilateral forearm blood ﬂow was measured during intrabrachial infusions of acetylcholine (ACh; 5 to 20 lg/min)
and sodium nitroprusside (SNP; 2 to 8 lg/min) in the presence of the NO clamp (NO synthase inhibitor NG-monomethyl-L-arginine (L-
NMMA) 8 lg/min coinfused with the NO donor SNP at 90 to 540 ng/min to restore basal blood ﬂow). Study 2: Blood pressure,
arterial stiffness, and cardiac output were measured during systemic NO synthase inhibition with intravenous L-NMMA (3 mg/kg).
Following diesel exhaust inhalation, plasma nitrite concentrations were increased (6848 versus 4132 nmol/L; P=0.006) despite
similar L-NMMA–induced reductions in basal blood ﬂow (20.614.7% versus 21.114.6%; P=0.559) compared to air. In the
presence of the NO clamp, ACh and SNP caused dose-dependent vasodilatation that was not affected by diesel exhaust inhalation
(P>0.05 for both). Following exposure to diesel exhaust, L-NMMA caused a greater increase in blood pressure (P=0.048) and central
arterial stiffness (P=0.007), but reductions in cardiac output and increases in systemic vascular resistance (P>0.05 for both) were
similar to those seen with ﬁltered air.
Conclusions-—Diesel exhaust inhalation disturbs normal vascular homeostasis with enhanced NO generation unable to
compensate for excess consumption. We suggest the adverse cardiovascular effects of air pollution are, in part, mediated through
reduced NO bioavailability.
Clinical Trial Registration-—URL: http://www.ClinicalTrials.gov. Unique identiﬁers: NCT00845767 and NCT01060930. ( J Am
Heart Assoc. 2013;2:e004309 doi: 10.1161/JAHA.112.004309)
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E xposure to air pollution increases cardiovascular mor-bidity and mortality,1–4 and is associated with the triggering of acute myocardial infarction.
5 Recent controlled
exposure studies in man have shown that inhalation of dilute
diesel exhaust, at environmentally relevant concentrations,
leads to an impairment of both vascular vasomotor and
ﬁbrinolytic function.6 Similarly, exposure to concentrated
ambient particles causes acute arterial vasoconstriction7 and
an increase in diastolic blood pressure.8 Although providing
plausible explanations for the increase in cardiovascular
events,9 the mechanisms of how air pollution induces these
cardiovascular abnormalities remain to be established.
Inhalation of ﬁne particulate matter causes inﬂammation
within the lungs,10,11 in part, through local oxidative
stress.12,13 Vascular oxidative stress may subsequently
develop as a consequence of the systemic response to
pulmonary inﬂammation and oxidative stress, or through
reactive oxygen species generation within the vascular wall
following translocation of particles into the circulation.14,15
Irrespective of the site of generation, it has been proposed
that this oxidative stress has a direct inﬂuence on the function
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of the vascular endothelium16 as well as reducing the vascular
bioavailability of nitric oxide (NO).6,17
NO is a powerful endogenous vasodilator and plays a
crucial role in the maintenance of basal vascular tone.18 In
patients with pre-existing vascular endothelial dysfunction,
such as those with hypercholesterolemia, stimulated endo-
thelium-dependent NO-mediated vasodilatation is impaired,
and this is thought to be mediated through oxidative stress-
mediated depression of NO bioavailability.19 In rats exposed
to inhaled particles, the generation of oxygen-centered free
radicals leads to the scavenging of NO, thereby reducing its
bioavailability.20
In this study, we investigated the hypothesis that changes
in NO bioavailability contribute to the cardiovascular dysfunc-
tion induced by diesel exhaust inhalation.
Methods
Subjects
Thirty-three healthy nonsmoking volunteers were recruited
from the Department of Medicine, Division of Respiratory
Medicine and Allergy, University Hospital, Umea, Sweden.
Subjects taking regular medication (excluding the oral contra-
ceptive pill), with a signiﬁcant occupational exposure to air
pollution or those with intercurrent illness were excluded. All
subjectswere free of symptoms of respiratory tract infection for
at least 6 weeks leading up to the study. The trial was
performed with the approval of the local research ethics
committee, in accordance with the Declaration of Helsinki, and
with the written informed consent of each participant.
Diesel Exhaust Exposure
Diesel exhaust was generated using an idling Volvo diesel
engine (Volvo TD40 GJE, 4.0 L, 4 cylinders, 680 rpm). Over
90% of the exhaust was shunted away, the remaining part
diluted with high-efﬁciency particulate air (HEPA) ﬁltered air
and fed into the exposure chamber at steady state concen-
tration. During the exposure, air was sampled in the breathing
zone of the subjects for oxides of nitrogen, particle mass
concentration and total hydrocarbons (measured as propane).
Filter samples were collected and analyzed gravimetrically to
determine mass concentration. The exposures were stan-
dardized based on particulate matter (particles with a mean
aerodynamic diameter ≤10 lm [PM10]) concentrations and a
mean airborne particle concentration of 31311 lg/m3 was
generated. The particle exposure was associated with
concentrations of nitrogen dioxide (NO2) of 0.90.1 ppm,
NO of 3.10.2 ppm and total hydrocarbons of 2.50.2 ppm.
Temperature and humidity in the chamber were controlled at
22°C and 50%, respectively.
Study Design
Subjects attended on 2 occasions at least 1 week apart. In 2
randomized double-blind crossover studies, subjects were
exposed to either ﬁltered air or dilute diesel exhaust at
300 lg/m3 in a specially built diesel exposure chamber as
described previously.21 During the exposures, subjects per-
formed 15-minute periods of exercise on a bicycle ergometer,
to achieve a mean minute ventilation of 20 L/min per m2 as
determined by a prestudy exercise test, alternating with
15 minutes of rest.
Based on previous studies, vascular assessments were
performed 2 hours after the exposure.6,22 All subjects
abstained from alcohol for 24 hours, caffeinated drinks for
8 hours and food for 4 hours prior to the cardiovascular
assessments, and remained indoors between the exposure
and assessments to minimize additional exposure to air
pollution. Venous blood samples were collected for measure-
ment of plasma nitrite concentration, endogenous NOS
inhibitors, and total and differential cell counts. Lung function
was determined by spirometry at baseline and 2 hours
following the exposure (Jaeger Masterlab, Jaeger AG) record-
ing forced vital capacity (FVC), forced expiratory volume in
1 second (FEV1), and slow vital capacity (VC).
Study 1: Local NO Synthase Inhibition
Eighteen subjects were recruited into this study. Forearm blood
ﬂow was determined using forearm venous occlusion plethys-
mography and detected using mercury-in-silastic strain gauges
placed around each forearm as described previously.23 All
subjects underwent unilateral brachial artery cannulation using
a 27-gauge steel needle (Coopers Needle Works Ltd) under
controlled conditions. After a 30-min baseline infusion of 0.9%
saline, subjects received an infusion of the NO synthase (NOS)
inhibitor NG-monomethyl-L-arginine (L-NMMA; Clinalfa basic,
Bachem) at incremental doses of 2, 4, and 8 lmol/min. The
infusion of L-NMMA was continued at 8 lmol/min for the
remainder of the study to fully inhibit all basal NOS activity.24,25
Sodium nitroprusside (SNP), an NO donor, was then coinfused
with L-NMMA at doses of 90 to 540 ng/min and titrated to
restore basal blood ﬂow. Once basal blood ﬂow was restored,
the SNP infusion was continued for the remainder of the study
to produce an “NO clamp” as described previously.24 This
permits the assessment of vascular function in the absence of
endogenous NO generation but without the potential con-
founding effects of basal vasoconstriction induced by isolated
NO synthase inhibition.
The dose-response relationship of the vasodilators acetyl-
choline (5, 10, and 20 lg/min6; endothelium-dependent NO
donor) and SNP (2, 4, and 8 lg/min6; endothelium-indepen-
dent NO donor) were assessed in the presence of the clamp.
The vasodilators were given in a random order and were
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separated by an infusion of 0.9% saline for 20 minutes. The
combined total infusion rate of the parallel infusions was kept
constant at 1 mL/min throughout the study.
Study 2: Systemic Nitric Oxide Synthase
Inhibition
Fifteen subjects were recruited into this study. Subjects had a
20-gauge arterial line inserted to the radial artery of the
non-dominant arm (Leader-Cath, Vygon SA). The arterial
catheter was attached to a validated pressure transducer
(Deltran II, Utah Medical Products) and data were recorded
in real-time using Powerlab instruments and LabChart
software (AD Instruments Pty Ltd). A validated semi-automatic
oscillometric sphygmomanometer was placed around the
upper arm of the dominant arm. Cardiac output, peripheral
resistance, and stroke index were recorded using thoracic
bioimpedence (Hotman, Hemo Sapiens, Inc) and central
arterial stiffness (pulse-wave velocity and pulse-wave analysis)
recorded using the Vicorder (Skidmore Medical) and Sphyg-
moCorTM apparatus (AtCor Medical).
After lying supine at rest for at least 20 minutes, L-NMMA
was infused intravenously over 5 minutes (total dose 3 mg/
kg)26 via a 17-gauge intravenous cannula inserted into a large
antecubital vein of the dominant arm, and hemodynamic
measurements were recorded for the following 45 minutes.
Biochemical Analyses
Blood samples were analyzed for total and differential cell
counts by an auto analyzer (Sysmex XE2100, Sysmex Europe
GmbH). Plasma samples were collected into ethylene diamine
tetra-acetic acid and kept on ice until centrifuged at 2000g
for 30 minutes at 4°C. Serum samples were collected and
left to clot on melting ice for 60 minutes before being
centrifuged at 2000g for 10 minutes at 4°C. Samples were
immediately frozen and stored at 80°C prior to subsequent
analysis.
Plasma was analyzed for the endogenous NOS inhibitors
asymmetric dimethylarginine (ADMA) and symmetric dime-
thylarginine (SDMA) as well as the NO precursors L-arginine
and L-homoarginine using a high-performance liquid chroma-
tography (HPLC) method as described previously.27 Brieﬂy,
arginine, homoarginine, ADMA, and SDMA were extracted
from plasma using Isolute PRS cation exchange solid phase
extraction columns (1 mL/50 mg; Kinesis Ltd). The columns
were consecutively washed with borate buffer (1 mL), water
(3 mL), and methanol (3 mL) before analytes were eluted with
3 mL of a solution containing 50% methanol and 10%
concentrated ammonia in water. The eluent was then
evaporated to dryness at 80°C under air. The dried extract
was then dissolved in 0.1 mL water and 0.1 mL of the
derivization reagent (10 mg of ortho-phthaldialdehyde dis-
solved in 0.2 mL methanol followed by the addition of 1.8 mL
of 200 nmol/L borate buffer and 10 lL of 3-mercaptoprop-
ionic acid, then diluted 5-fold using 200 nmol/L borate buffer
immediately before use) before being transferred to auto-
sampler vials, maintained at 10°C, and 20 lL was injected
into the HPLC analytical column for chromatography. Follow-
ing separation, arginine, homoarginine, ADMA, and SDMA
were measured ﬂuorimetrically (Waters 2475, Waters) and
quantiﬁed using single-level calibration using an internal
standard (80 lL of 5 lmol/L monoethylarginine) added
before sample extraction.
Blood samples obtained for the measurement of plasma
nitrite were collected into lithium heparin, immediately
transferred to Eppendorf tubes prewashed with Milli-Q
deionized water, and immediately centrifuged at 5000g for
1 minute. Plasma was then transferred into a dark colored
Eppendorf tube containing 100 lL of a solution containing
1 mmol/L diethylenetriamine-pentaacetic acid and 62.5 mmol/L
N-ethylmaleimide before being snap-frozen on dry ice and
stored at 80°C prior to further analysis.
Plasma nitrite samples were defrosted on ice before 100 lL
was injected into a reaction vial containing glacial acetic acid
and iodide.28 NO generated in the reaction chamber was driven
off by a continual stream of oxygen-free nitrogen and detected
in the exhaust gas using a Sievers NOA 280i chemiluminescent
analyzer (Analytix, Co). Analyses were performed in triplicate.
The limit of detection of this assay was 30 nmol/L with a
coefﬁcient of variation of 3.1% for a 250 nmol/L standard.
Data Analysis and Statistics
Plethysmography data were analyzed as described previ-
ously.29,30 Data are expressed as meanstandard deviation
(SD) unless otherwise stated. Statistical analyses were
performed using Student’s paired t-tests and 2-way analysis
of variance (ANOVA) with repeated measures where appro-
priate. Statistical signiﬁcance was taken as 2-sided P<0.05.
All analyses were performed using GraphPad Prism (Version 4
for Macintosh, GraphPad Software) on a Macintosh personal
computer.
Results
Thirty subjects completed the study protocols (Table 1) with 5
subjects common to both protocols. All studies were generally
well tolerated with no signiﬁcant adverse events. There were
no changes in any indices of lung function (FEV1, FVC, and VC)
or in hemoglobin concentration, white cell count (or differen-
tial cell counts) or platelet count throughout all studies
(P>0.05 for all; data not shown).
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Plasma Nitrite and Arginine Concentrations
Two hours following exposure to diesel exhaust, plasma nitrite
concentrations were higher as compared to the ﬁltered air
exposure (6848 versus 4132 nmol/L; P=0.006). In con-
trast, there were no differences in plasma concentrations of
the NO precursor L-homoarginine, or in the endogenous NOS
inhibitors ADMA and SDMA at 2 or 6 hour following
exposures (Table 2). Plasma concentrations of the NO
precursor L-arginine were lower after exposure to diesel
exhaust as compared to ﬁltered air (P=0.043).
Study 1: Local Nitric Oxide Synthase Inhibition
Sixteen subjects, median age 23 years (Table 1), completed
the study protocol: one subject failed to attend scheduled
visits and one was withdrawn for technical reasons (failed
cannulation). Blood pressure, heart rate, and baseline forearm
blood ﬂow were not different following either exposure
(P>0.05 for all; data not shown).
Infusion of the NOS inhibitor, L-NMMA, resulted in a
similar dose-dependent vasoconstriction following both
exposures (P=0.559; Figure 1A). After establishing the NO
clamp by restoring basal blood ﬂow with SNP coinfusion
(20833 and 23626 ng/min following air and diesel
exhaust exposure respectively; P=0.453), both acetylcholine
and SNP caused dose-dependent vasodilatation (P<0.01 for
both) that was attenuated in comparison to previous
studies.6 However, this vasodilatation was similar following
both exposures (dilute diesel exhaust versus ﬁlter air:
P=0.209 for acetylcholine and P=0.613 for sodium nitro-
prusside; Figure 1B).
Study 2: Systemic Nitric Oxide Synthase
Inhibition
Fourteen subjects, median age 26 years (Table 1), completed
the study protocol: one subject was withdrawn for technical
reasons (failed cannulation). There were no differences in
hemodynamic or biochemical indices at baseline prior to
either exposure (Table 3).
Following exposure to diesel exhaust, L-NMMA caused a
greater increase in blood pressure (P=0.048) and central
arterial stiffness (P=0.007) with similar reductions in cardiac
Table 1. Baseline Characteristics of Study Participants
Baseline Characteristics
Study 1: Forearm
Study (n=16)
Study 2: Systemic
L-NMMA (n=14)
Age, y (median, range) 23 (21 to 27) 26 (23 to 34)
Male/Female 9 (56%)/7 (44%) 8 (57%)/6 (43%)
Use of oral
contraceptive
(female)
5 (72%) 3 (50%)
Height, cm
All 1769 17811
Male 1817 1866
Female 1696 1675
Weight, kg
All 7213 7414
Male 8011 856
Female 604 603
BMI, kg/m2
All 23.12.8 23.22.1
Male 24.62.8 24.61.4
Female 21.21.0 21.51.5
Data expressed as meanstandard deviation unless otherwise stated. L-NMMA indicates
NG-monomethyl-L-arginine; BMI, body mass index.
Table 2. Plasma Concentrations of NOS Substrates and Endogenous NOS Inhibitors
Parameter Exposure Baseline 2 Hour 6 Hour
P value
Time Exp
L-Arginine, lmol/L Air 74.116.3 61.617.8 59.310.6 0.006 0.006
Diesel 67.713.4 58.210.0 54.610.3
L-Homoarginine, lmol/L Air 1.750.46 1.660.48 1.700.51 0.913 0.412
Diesel 1.670.51 1.630.48 1.690.53
ADMA, lmol/L Air 0.520.08 0.440.09 0.510.07 0.010 0.374
Diesel 0.510.05 0.440.06 0.500.07
SDMA, lmol/L Air 0.430.06 0.410.07 0.430.05 0.451 0.449
Diesel 0.410.05 0.410.05 0.430.05
Plasma concentrations of endogenous NOS inhibitors and NOS substrates at baseline, 2 and 6 hours after the exposure during Study 1 (local L-NMMA administration). All data expressed
as meanstandard deviation. P-values from 2-way repeated measures ANOVA. NOS indicates nitric oxide synthase; ADMA, asymmetric dimethylarginine; SDMA, symmetric
dimethylarginine.
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output and increases in systemic vascular resistance (P>0.05
for both) as compared to ﬁltered air (Figure 2).
Discussion
We have demonstrated that inhalation of dilute diesel exhaust
increases plasma nitrite concentrations suggesting an
increase in basal NO release. However, local NO synthase
inhibition causes similar degrees of vasoconstriction following
both diesel exhaust and ﬁltered air exposure. This suggests a
balanced increase in basal NO generation and consumption
that attempts to maintain basal peripheral resistance vessel
tone. This is consistent with our observation that diesel
exhaust inhalation-induced vasomotor dysfunction31 is no
longer demonstrable in the presence of the NO clamp. In
contrast to the peripheral resistance vessel responses,
systemic NO synthase inhibition demonstrated an increase
in systemic arterial stiffness and blood pressure suggesting
that, in conduit vessels, reduced NO bioavailability has more
marked effects that cannot be adequately compensated for by
increased basal NO release.
We demonstrated higher basal venous plasma nitrite
concentrations following diesel exhaust exposure. These data
are consistent with the upregulation of vascular NO genera-
tion, which we suggest may represent a homeostatic
feedback loop to compensate for increased consumption by
local oxidative stress in order to maintain basal vascular tone
and blood pressure. While it is unlikely that changes in NO
generation reﬂect upregulation of gene expression, there is
growing evidence that endothelial NOS (eNOS) can be rapidly
upregulated or induced by enzyme phosphorylation and
alterations in protein–protein interactions32 and we suggest
that these interactions are responsible for the increased NO
generation due to local inﬂammation and oxidative stress.
Indeed, these interactions occur very rapidly in animal
models, with LPS-induced inﬂammation increasing eNOS
activity almost 2-fold within 1 hour.33 We believe this effect
is likely to be driven by changes in eNOS activity although the
exact isoform of the NOS enzyme responsible is unclear from
our study given the nonselective inhibition by L-NMMA.
Previous studies in murine models have demonstrated an
increase in inducible-NOS (iNOS) expression following expo-
sure to dilute diesel exhaust,34,35 and certainly iNOS has the
capacity to be rapidly upregulated in response to insult. The
possibility of an effect on iNOS expression remains unex-
plored at this time.
Figure 1. A, Forearm blood ﬂow response during infusion of L-NMMA (2-way repeated measures ANOVA: P=0.559 for exposure). B, Forearm
blood ﬂow during infusion of the vasodilators acetylcholine and sodium nitroprusside (2-way repeated measures ANOVA: P=0.209 and P=0.613,
respectively, for exposure). Data expressed as meanSEM. L-NMMA indicates NG-monomethyl-L-arginine; ANOVA, analysis of variance; SEM,
standard error of the mean.
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We have previously demonstrated in isolated rat aortic
rings that diesel exhaust particles attenuate endothelium-
derived vasorelaxation. This effect was reversed by coincu-
bation with superoxide dismutase thereby reducing oxygen-
centered free radical production.36 We have also shown that
diesel exhaust particles themselves reduce the concentra-
tions of bioavailable NO from the NO donor DEA/NO (2-(N,N-
diethylamino)-diazenolate-2-oxide).19 Nurkiewicz and col-
leagues have reported that, following inhalation of titanium
dioxide nanoparticles, local NO was scavenged by oxygen-
centered free radicals.20 This reduction in NO bioavailability
appears to be driven either by the uncoupling of endothelial
NOS by diesel exhaust particles or by local oxidative stress.37
However, while reﬂective of production and consumption of
NO across the vascular bed, plasma nitrite concentrations do
not deﬁnitively describe the activity of the NOS enzymes and
their isoforms. It remains feasible that some of the increase in
plasma nitrite is in fact due to absorption from the higher
oxides of nitrogen during the exposure itself. Knuckles and
colleagues have recently reported that following diesel
exhaust exposure, rats had increased plasma NOx (nitrate
and nitrite combined) concentrations that appeared to be
predominantly the result of absorption of NO from the
exposure itself, although they exhibited signiﬁcant increases in
eNOS expression consistent with increased NO production.38
Controlled exposures to NO and nitrogen dioxide in humans
with subsequent measurements of plasma nitrite concentra-
tions may help to deﬁne this further.
The concept of local oxidative stress is thought to underlie
vascular endothelial dysfunction in clinical states such as
hypertension, diabetes mellitus, and hypercholesterolemia,39
and has been proposed as the central mechanism linking the
cardiovascular, respiratory, and inﬂammatory responses to
inhaled particulate air pollution.40 Measurement of oxidative
stress is, however, extremely difﬁcult to quantify due to the short
half-life and high reactivity of free radicals, and because we are
largely left to measure surrogate markers such as isoprostanes
and oxidative DNA adducts to determine increases in free radical
production in clinical models. As such, the clinical evidence for
increased oxidative stress following exposure to air pollutants is
limited, and existing studies are inconsistent, although a recently
published meta-analysis suggests that there is a robust
relationship between exposure to particulate air pollution and
increases in oxidative DNA adducts and oxidized lipids in man.41
While outside of the scope of this study, we have previously
measured plasma nitrotyrosines and urinary isoprostanes
following exposure to dilute diesel exhaust, and these results
are presented in an online supplement (Data S1).
Although the plasma concentration of the NO precursor L-
arginine was generally lower after exposure to diesel exhaust,
plasma concentrations of L-homoarginine were unaffected and
there were no changes in concentration over time. These
precursors, L-arginine and L-homoarginine, are present in vast
molar excess as only 1.2% of plasma arginine used for whole-
body NO production.42,43 The small differences in plasma
concentration, which are most likely attributable to dietary
intake, are of little functional signiﬁcance and cannot account
for differences in NO production or availability. Similarly, given
the small amount of L-arginine/L-homoarginine required to
produce NO, we suggest short-term modest increases in NO
generation are unlikely to affect their plasma concentrations
or indeed those of the naturally occurring endogenous NOS
inhibitors, such as ADMA.
Individuals with hypercholesterolemia have impaired vas-
cular vasomotor dysfunction: the classic paradigm of vascular
endothelial dysfunction as a result of changes in the
Table 3. Baseline Hemodynamic and Biochemical
Parameters Prior to Exposure for the Systemic
Administration of L-NMMA Study
Parameter Air Diesel
Heart rate, bpm 6713 658
Systolic blood pressure, mm Hg 12412 12416
Diastolic blood pressure, mm Hg 706 706
Mean arterial pressure, mm Hg 886 888
Pulse wave velocity, m/s 5.80.6 5.80.5
Augmentation index (AIx), % 39 110
AIx75, % 89 611
Augmentation pressure, mm Hg 14 04
Time to wave reﬂection, ms 16420 17238
Cardiac index, L/min per m2 4.80.8 5.00.8
Stroke index, mL/beat per m2 7612 8117
PVRI, dynes.min/cm5 per m2 9120 8826
Hemoglobin, g/dL 14414 14012
Hematocrit, % 412 413
White cell count, 9109/L 5.90.9 5.50.8
Neutrophil count, 9109/L 3.10.8 2.70.7
Monocyte count, 9109/L 0.50.2 0.50.1
Lymphocyte count, 9109/L 2.00.3 2.10.4
Platelet count, 9109/L 22438 22633
Blood urea nitrogen, mg/dL 16.87.6 16.87.6
Creatinine, mg/dL 0.850.16 0.850.16
Sodium, mmol/L 1411 1411
Potassium, mmol/L 4.30.3 4.20.3
TCO2, mmol/L 283 282
eGFR, mL/min per 1.73 m2 12126 12226
Data expressed as meanstandard deviation. L-NMMA indicates NG-monomethyl-L-
arginine; bpm, beats per minute; AIx, augmentation index corrected for a heart rate of
75 bpm; PVRI, peripheral vascular resistance index; TCO2, total carbon dioxide; eGFR,
estimated glomerular ﬁltration rate.
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Figure 2. Changes in invasive mean arterial blood pressure, central arterial stiffness (PWV), cardiac index, and stroke volume following systemic
infusion of L-NMMA. Data expressed as meanSEM and composite area under the curve with 2-way repeated measures ANOVA for exposure.
PWV indicates pulse-wave velocity; L-NMMA, NG-monomethyl-L-arginine; SEM, standard error of the mean; ANOVA, analysis of variance.
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L-arginine-NO pathway.44,45 However, these subjects have
normal responses to NOS inhibition with L-NMMA, but
reduced vasodilatation to endothelium-dependent vasodila-
tors such as acetylcholine and serotonin.46 In the present
studies, we demonstrate the same pattern of vascular
dysfunction following the inhalation of dilute diesel exhaust.
Indeed, in the presence of the NO clamp, and the absence of
endogenous NO release, the previously demonstrated atten-
uation in vascular vasomotor responses following diesel
exhaust inhalation31 is abolished. These ﬁndings are consis-
tent with the suggestion that basal NO generation is already
increased so further stimulation may be proportionately less
effective, and that the NO released may be consumed more
rapidly by local oxidative stress. Furthermore, given that the
responses to stimulation with acetylcholine are similar in the
absence of endogenous NO release, this would suggest that
the other key vasodilator mechanisms, such as endothelium-
derived hyperpolarising factor (EDHF) or prostaglandins, are
intact and unaffected by diesel exhaust inhalation.
Administration of the exogenous NOS inhibitor, L-NMMA,
had the anticipated response of causing peripheral vasocon-
striction and a systemic pressor response with reduced
cardiac output.26,47–51 The control of basal vascular tone and
vascular reactivity is complex and is known to vary in the
different vascular beds. The regulation of conduit arterial tone
is almost solely dependent on endothelial NO production, and
alternative vasodilator mechanisms, such as EDHF, appear to
play little role.52 In contrast, the vasomotor responses in
resistance vessels are mediated through NO, EDHF, and
prostaglandin pathways.53,54 Indeed, endogenous NO release
reﬂects only lower levels of vasodilatation, with EDHF
compensating and providing a greater contribution to the
vasomotor response especially with higher degrees of vaso-
dilatation. We therefore suggest that in the conduit vessels,
the increase in endogenous NO production following diesel
exhaust inhalation can offset the increased consumption of
NO in the context of increased local oxidative stress, thus
suppressing a potential pressor effect. However, in the
presence of systemic NOS inhibition, this potential pressor
effect is unmasked and we see an increase in blood pressure
and arterial stiffness. This enhanced sensitivity of the central
arterial tree may underlie the increases in blood pressure
seen with acute8,55 and chronic56 exposures to particulate air
pollutants. Alternatively, the increase in NO concentrations
following exposure to diesel exhaust may reﬂect increased
bioavailability of NO within the vasculature, and an enhanced
pressor response to systemic L-NMMA infusion. However, this
would not be consistent with the similar basal blood ﬂow and
vasomotor response to L-NMMA in the forearm circulation.
While we suggest that changes in NO bioavailability are
consistent with our ﬁndings, a similar effect may be seen with
other mechanisms, such as activation of the autonomic
nervous system. Such activation will also cause an increase in
vascular tone as well as a pressor and arterial stiffness
response. Indeed, changes in autonomic nervous system
activation may underlie the acute vasoconstriction7 and
changes in heart rate variability previously reported.57 Further
studies are warranted to evaluate the contribution of the
autonomic nervous system to these important vascular
effects.
Limitations
This study was undertaken in order to examine changes in
blood pressure and arterial vasomotor function as measured
by venous occlusion plethysmography. While the robust
crossover design increases the statistical power of the
study, we recognize that for some secondary outcomes this
study may have been unable to deﬁnitively identify a lack of
effect.
Conclusions
In these studies we have demonstrated for the ﬁrst time in
humans that inhalation of dilute diesel exhaust results in
higher basal plasma nitrite concentrations. This is consistent
with homeostatic regulation in the presence of increased NO
consumption due to local oxidative stress. Similarly, we have
shown that in the presence of the NO clamp and the absence
of endogenous NO production, diesel exhaust inhalation does
not result in further vascular impairment. Furthermore, diesel
exhaust inhalation exaggerates the pressor and vasoconstric-
tor effects of systemic NO synthase inhibition consistent with
the proposed changes in NO production and consumption. We
conclude that the vascular dysfunction associated with diesel
exhaust inhalation is mediated predominantly by reduced NO
bioavailability.
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